BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20206795)

  • 1. Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers.
    Kim BH; Kim KP; Lim KS; Kim JR; Yoon SH; Cho JY; Lee YO; Lee KH; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2010 Feb; 32(2):380-90. PubMed ID: 20206795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial.
    Small DS; Payne CD; Kothare P; Yuen E; Natanegara F; Teng Loh M; Jakubowski JA; Richard Lachno D; Li YG; Winters KJ; Farid NA; Ni L; Salazar DE; Tomlin M; Kelly R
    Clin Ther; 2010 Feb; 32(2):365-79. PubMed ID: 20206794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Di Girolamo G; Czerniuk P; Bertuola R; Keller GA
    Clin Ther; 2010 Jan; 32(1):161-70. PubMed ID: 20171421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects.
    Aruna D; Naidu MU
    Br J Clin Pharmacol; 2007 Mar; 63(3):333-8. PubMed ID: 17010102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine.
    Lu WJ; Huang JD; Lai ML
    J Clin Pharmacol; 2006 Jun; 46(6):628-34. PubMed ID: 16707409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between ticlopidine or warfarin or cardioaspirin with a highly standardized deterpened Ginkgo biloba extract (VR456) in rat and human.
    Di Pierro F; Rinaldi F; Lucarelli M; Rossoni G
    Acta Biomed; 2010 Dec; 81(3):196-203. PubMed ID: 22530457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and safety of a fixed-dose combination of acetylsalicylic acid and clopidogrel compared with the concurrent administration of acetylsalicylic acid and clopidogrel in healthy subjects: a randomized, open-label, 2-sequence, 2-period, single-dose crossover study.
    Jung JA; Kim TE; Kim JR; Kim MJ; Huh W; Park KM; Lee SY; Ko JW
    Clin Ther; 2013 Jul; 35(7):985-94. PubMed ID: 23870608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers.
    Blonk M; Colbers A; Poirters A; Schouwenberg B; Burger D
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5070-5. PubMed ID: 22802250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies.
    Kim BH; Kim JR; Kim MG; Kim KP; Lee BY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2010 Jan; 32(1):193-205. PubMed ID: 20171424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers.
    Kim KP; Kim BH; Lim KS; Kim TE; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2098-106. PubMed ID: 19922880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761).
    Kim YS; Pyo MK; Park KM; Park PH; Hahn BS; Wu SJ; Yun-Choi HS
    Thromb Res; 1998 Jul; 91(1):33-8. PubMed ID: 9700851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects.
    Kim HS; Kim GY; Yeo CW; Oh M; Ghim JL; Shon JH; Kim EY; Kim DH; Shin JG
    Br J Clin Pharmacol; 2014 May; 77(5):821-30. PubMed ID: 24001154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers
.
    Nakkam N; Tiamkao S; Kanjanawart S; Phunikhom K; Tiamkao S; Vannaprasaht S; Tassaneeyakul W; Tassaneeyakul W
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):177-185. PubMed ID: 27936524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic comparison of orally disintegrating and conventional donepezil formulations in healthy Korean male subjects: a single-dose, randomized, open-label, 2-sequence, 2-period crossover study.
    Kim KA; Lim JL; Kim C; Park JY
    Clin Ther; 2011 Jul; 33(7):965-72. PubMed ID: 21723605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?
    Wolf HR
    Drugs R D; 2006; 7(3):163-72. PubMed ID: 16752942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers.
    Köhler S; Funk P; Kieser M
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):303-9. PubMed ID: 15166915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjects.
    Kim BH; Kim JR; Lim KS; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Drug Investig; 2012 Dec; 32(12):817-26. PubMed ID: 23026843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.